MindBio Therapeutics Corp. MBQIF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -141.44% | -541.50% | -2,474.27% | -438.53% | -1,269.90% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.07% | 1,769.33% | 1,228.80% | 168.93% | 1,231.12% |
| Change in Net Operating Assets | 120.23% | -198.95% | -103.37% | 2,098.40% | -2,518.52% |
| Cash from Operations | -944.79% | -449.02% | 48.79% | -735.58% | -143.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 89.68% | -- |
| Issuance of Common Stock | -- | 604.91% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 610.14% | -- | 2,213.25% | -- |
| Foreign Exchange rate Adjustments | -1,841.94% | -- | -- | 70.18% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -541.10% | 1,514.81% | 53.38% | 145.38% | -140.51% |